This exclusive article is by Dr. Ralph Vogelsang, Senior Director of Business Development & Licensing, ERS Genomics. Conventional drug discovery models, such as animal models or human cell lines,...
After a stroke, survivors often experience uncontrollable spasms that can twist their arms and hands into perpetual fists. The only treatments are expensive, frequently painful injections of botulinum toxin...
Partnerships between small biotechs and Big Pharma could unlock faster drug development for rare diseases, says Dan Williams, PhD, CEO of SynaptixBio. In an increasingly interconnected and competitive world,...
Targeted Alpha Therapy (TAT) is a promising cancer treatment in nuclear medicine, but the supply of alpha-emitting radionuclides – which the treatment relies on – is very limited. A...
The world’s most extensive clinical study into liver cirrhosis has been announced by Newcastle University, University of Edinburgh and r esearch-driven global biopharmaceutical company, Boehringer Ingelheim. The ADVANCE (Accelerating...
Parents of newborns might feel like they have aged a few years in those early months of sleepless nights. Now, scientists at the University of Leicester are investigating whether...